Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...
Prostate cancer is absurdly common, but many men are mum about it. Joe Biden’s diagnosis has focused public attention on it. Good morning. I’m Mark Shanahan, guest-writing Starting Point to tell you ...
The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...
It should come as no surprise that the recent revelation that former President Joe Biden has an aggressive form of prostate cancer drew a broad spectrum of reactions from the sympathetic to the ...
The Independent on MSN
Men with BRCA gene mutations ‘should be given annual prostate cancer checks’
Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said. Experts at the Institute of Cancer Research (ICR) in London said men with ...
Men with long index fingers are at lower risk of prostate cancer, a study found. British scientists who compared the hands of 1,500 prostate-cancer patients and 3,000 healthy men found that those ...
Apr. 24, 2023 7:30 AM ETLantheus Holdings, Inc. (LNTH), PNT Lantheus in-licensed exclusive worldwide commercialization rights (excluding certain Asian territories) to 177 Lu-PNT2002 from POINT in ...
BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback